We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
+7.98%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$480M
AUM Growth
+$96.7M
(+25%)
Cap. Flow
+$82.2M
Cap. Flow
% of AUM
17.13%
Top 10 Holdings %
Top 10 Hldgs %
19.96%
Holding
645
New
258
Increased
78
Reduced
78
Closed
231
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$45.7M |
| 2 |
Nasdaq
NDAQ
|
+$5.95M |
| 3 |
Fidelity National Information Services
FIS
|
+$5.66M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
+$5.09M |
| 5 |
Novartis
NVS
|
+$5.01M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$5.84M |
| 2 |
ExxonMobil
XOM
|
+$5M |
| 3 |
CrowdStrike
CRWD
|
+$4.96M |
| 4 |
British American Tobacco
BTI
|
+$4.57M |
| 5 |
Blackstone
BX
|
+$4.42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.69% |
| 2 | Consumer Discretionary | 15.64% |
| 3 | Healthcare | 14.23% |
| 4 | Financials | 8.55% |
| 5 | Communication Services | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Devon Energy
DVN
$51.4B
| $764K | 0.16% |
15,094
+1,250
| +9% | +$71.1K |
|
177
Constellation Energy
CEG
$97.7B
| $763K | 0.16% |
9,721
+6,690
| +221% | +$541K |
|
178
ICICI Bank
IBN
$109B
| $759K | 0.16% |
+35,166
| New | +$734K |
|
179
Public Service Enterprise Group
PEG
$38.2B
| $754K | 0.16% |
+12,080
| New | +$732K |
|
180
Flowers Foods
FLO
$1.53B
| $746K | 0.16% |
+27,231
| New | +$751K |
|
181
Equifax
EFX
$20.5B
| $744K | 0.16% |
+3,668
| New | +$764K |
|
182
National Vision
EYE
$1.8B
| $744K | 0.15% |
+39,472
| New | +$1.28M |
|
183
H&R Block
HRB
$5.73B
| $742K | 0.15% |
+21,050
| New | +$778K |
|
|
ITCI
184
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $739K | 0.15% |
+13,655
| New | +$660K |
|
185
HP
HPQ
$24.8B
| $737K | 0.15% |
25,096
+13,840
| +123% | +$397K |
|
186
Clearfield
CLFD
$436M
| $720K | 0.15% |
+15,449
| New | +$995K |
|
187
Fastenal
FAST
$55.2B
| $717K | 0.15% |
26,600
+15,766
| +146% | +$404K |
|
188
LyondellBasell Industries
LYB
$19.6B
| $716K | 0.15% |
+7,626
| New | +$709K |
|
189
Pentair
PNR
$10.7B
| $706K | 0.15% |
12,765
+6,349
| +99% | +$337K |
|
|
NATI
190
DELISTED
National Instruments Corp
NATI
| $693K | 0.14% |
13,227
+6,007
| +83% | +$301K |
|
191
Payoneer
PAYO
$2.4B
| $693K | 0.14% |
+110,321
| New | +$656K |
|
192
Quest Diagnostics
DGX
$25.6B
| $691K | 0.14% |
4,884
-4,379
| -47% | -$627K |
|
193
General Dynamics
GD
$103B
| $678K | 0.14% |
+2,972
| New | +$687K |
|
194
Liberty Global Class A
LBTYA
$3.71B
| $673K | 0.14% |
+34,530
| New | +$702K |
|
195
Coinbase
COIN
$38.7B
| $668K | 0.14% |
+9,885
| New | +$592K |
|
196
Bristol-Myers Squibb
BMY
$134B
| $667K | 0.14% |
+9,622
| New | +$679K |
|
197
Burlington
BURL
$23.2B
| $667K | 0.14% |
+3,299
| New | +$721K |
|
198
ZTO Express
ZTO
$18.7B
| $663K | 0.14% |
+23,130
| New | +$631K |
|
199
Qiagen
QGEN
$8.73B
| $661K | 0.14% |
13,566
-1,649
| -11% | -$83.9K |
|
200
Mondelez International
MDLZ
$78.8B
| $660K | 0.14% |
9,473
-1,214
| -11% | -$80.4K |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q1 2023 Portfolio in Review
As of Q1 2023, Seven Eight Capital held 645 positions worth $480M, up 25% from $383M the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Seven Eight Capital deployed $82.2M of net new capital in Q1 2023, opening 258 new positions and adding to 78 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 114,438 shares worth $46.8M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Advanced Micro Devices, an estimated $5.84M trimmed.
- Seven Eight Capital's largest Q1 2023 buy was State Street SPDR S&P 500 ETF Trust: 114,438 shares worth $46.8M.
- Seven Eight Capital added most to BioMarin Pharmaceuticals in Q1 2023, an estimated $5.09M increase.
- Seven Eight Capital's biggest Q1 2023 reduction was Advanced Micro Devices, cutting an estimated $5.84M.
- Seven Eight Capital fully exited ExxonMobil in Q1 2023, selling an estimated $5M.
- Seven Eight Capital's ten largest holdings make up 20% of its $480M portfolio in Q1 2023.
- Seven Eight Capital opened 258 new positions and closed 231 in Q1 2023.
- Seven Eight Capital's portfolio value rose 25% quarter-over-quarter to $480M.
Based on Seven Eight Capital's 13F filing for Q1 2023, filed 15 May 2023.